Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWTR.L Regulatory News (WTR)

  • There is currently no data for WTR

Interim Management Statement

3 Feb 2016 12:21

RNS Number : 9630N
World Trust Fund (The)
03 February 2016
 

The World Trust Fund

Interim Management Statement

 for the quarter ended 31st December 2015

 

The World Trust Fund (the "Fund") is publishing this Interim Management Statement in accordance with the Luxembourg law of 11 January 2008 on Transparency requirements (the "Transparency law").

 

This Interim Management Statement has been produced solely to provide additional information to shareholders as a body to meet the relevant requirements of the Transparency law. It should not be relied upon by any other party or for any other purpose.

 

This Interim Management Statement relates to the period from 1 October 2015 to 31 December 2015 and contains information that covers this period and the period up to the date of publication of this Interim Management Statement.

 

The Fund aims to achieve long-term capital appreciation by investing in companies, in the main closed-end investment companies, whose shares trade at a discount to their underlying net asset value and are listed on international exchanges. For hedging purposes the Fund may also sell short stock indices, stocks, and shares of exchange-traded funds or closed-end funds, not exceeding 100% of the Fund's net assets.

 

Highlights:

Over the 3 month period from 1 October 2015 to 31 December 2015:

 

· The Fund's diluted net asset value (NAV) rose 7.5% to $4.376 in US$ terms (base currency), compared with a rise of 5.0% in the MSCI All Countries World Index.

· The Fund's share price rose in Sterling terms by 8.9% to 252 pence.

· The discount to NAV (in Sterling) at the end of the period was -15.1%.

· The Fund's underlying holdings had an average weighted discount of -22.5%.

 

 

Long Term Performance:

 

1-Year

3-Year**

5-Year**

10-Year**

Share Price £

+3.8%

+9.1%

+5.1%

+1.7%

Share Price US$*

-1.8%

+5.6%

+4.0%

+0.2%

Net Asset Value £*

+6.6%

+11.0%

+6.5%

+2.6%

Net Asset Value US$

+0.7%

+7.5%

+5.3%

+1.0%

MSCI All Countries World US$

-2.4%

+7.7%

+6.1%

+4.8%

MSCI AC World Ex USA

-5.7%

+1.5%

+1.1%

+2.9%

 

The MSCI All Countries World index is shown solely for the purpose of performance comparison, and in no way reflects the composition of the portfolio.

*Converted using Foreign Exchange rate used by the administrator.

** Annualized.

Top Five Holdings (%):

31/12/15

30/09/15

BB Biotech

7.2%

6.9%

Eurazeo

5.7%

5.8%

JPMorgan European Smaller Companies

5.4%

5.0%

General American Investors

5.4%

5.7%

Investor AB

4.7%

4.7%

 

 

 

 

 

Top 5 Regional Breakdown (%)

31/12/15

30/09/15

North America

23.0%

29.2%

Asia (ex-Japan)

25.1%

27.6%

Europe (ex-UK)

21.2%

21.6%

United Kingdom

10.8%

9.6%

Japan

9.5%

9.2%

 

 

31/12/15

30/09/15

Long Exposure

98.8%

101.0%

Short Exposure

0%

0.0%

Net Exposure

98.8%

101.0%

 

 

Top 10 Country Weightings (%)

 

31/12/15

United States

22.7

China

12.9

United Kingdom

10.8

Japan

9.5

France

5.7

Sweden

4.8

Switzerland

3.8

India

2.9

Philippines

2.3

Hong Kong

2.0

 

 

Leverage:

As at 31 December 2015 the Fund had no leverage.

 

Material Transactions and Events:

 

Since the period end the Fund paid a dividend of 1.0p per share on 15 January 2016 to its shareholders who appeared on its register on 18 December 2015.

 

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSLLFLFFTIVIIR
Date   Source Headline
6th Jul 20182:14 pmBUSNet Asset Value(s)
5th Jul 20184:33 pmRNSHoldings In Other Investment Companies
4th Jul 201811:39 amBUSNet Asset Value(s)
3rd Jul 20184:16 pmRNSTotal Voting Rights
3rd Jul 201811:00 amBUSNet Asset Value(s)
2nd Jul 20182:21 pmRNSMay 2018 Fact Sheet
2nd Jul 201811:36 amBUSNet Asset Value(s)
29th Jun 201811:46 amBUSNet Asset Value(s)
28th Jun 201812:11 pmBUSNet Asset Value(s)
27th Jun 201811:29 amBUSNet Asset Value(s)
26th Jun 201811:00 amBUSNet Asset Value(s)
25th Jun 201811:20 amBUSNet Asset Value(s)
22nd Jun 201812:07 pmBUSNet Asset Value(s)
21st Jun 201811:55 amBUSNet Asset Value(s)
20th Jun 201812:03 pmBUSNet Asset Value(s)
19th Jun 201811:54 amBUSNet Asset Value(s)
18th Jun 201811:40 amBUSNet Asset Value(s)
18th Jun 20187:00 amRNSTransaction in Own Shares
15th Jun 201812:53 pmRNSEdison issues review on Lazard World Trust Fund
15th Jun 201811:52 amBUSNet Asset Value(s)
14th Jun 201812:15 pmBUSNet Asset Value(s)
13th Jun 201811:27 amBUSNet Asset Value(s)
12th Jun 201812:32 pmBUSNet Asset Value(s)
11th Jun 201811:59 amBUSNet Asset Value(s)
8th Jun 201812:05 pmBUSNet Asset Value(s)
7th Jun 201812:12 pmBUSNet Asset Value(s)
6th Jun 20185:52 pmRNSReplacement - Transactions in a close period
6th Jun 20185:17 pmRNSTransaction in Own Shares
6th Jun 201810:49 amBUSNet Asset Value(s)
5th Jun 20184:20 pmRNSTransaction in Own Shares
5th Jun 201811:52 amBUSNet Asset Value(s)
4th Jun 201812:33 pmBUSNet Asset Value(s)
4th Jun 20187:00 amRNSTransaction in Own Shares
1st Jun 201811:41 amBUSNet Asset Value(s)
31st May 20183:00 pmRNSTransactions in a close period
31st May 201812:10 pmBUSNet Asset Value(s)
30th May 201812:08 pmBUSNet Asset Value(s)
30th May 20189:13 amRNSApril Fact Sheet
29th May 20187:00 amBUSNet Asset Value(s)
25th May 201811:45 amBUSNet Asset Value(s)
24th May 201811:30 amBUSNet Asset Value(s)
23rd May 201812:12 pmBUSNet Asset Value(s)
22nd May 20186:25 pmBUSNet Asset Value(s)
22nd May 201811:00 amBUSNet Asset Value(s)
18th May 201811:37 amBUSNet Asset Value(s)
17th May 201811:52 amBUSNet Asset Value(s)
16th May 201812:05 pmBUSNet Asset Value(s)
15th May 201812:13 pmBUSNet Asset Value(s)
14th May 201811:34 amBUSNet Asset Value(s)
11th May 20185:45 pmBUSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.